Secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the Efficacy of Response And Safety of 2 fixed secUkinumab REgimens in psoriasis (ERASURE)

被引：0
|
作者：
Elewski, B.
Lebwohl, M.
Papp, K.
Nakagawa, H.
Sigurgeirsson, B.
Tsai, T.
Tyring, S.
Hampele, I.
Karpov, A.
Helou, S.
Papavassilis, C.
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [11] Effectiveness and safety of secukinumab in patients with moderate to severe plaque psoriasis
    Moron, R.
    Alvarez, R.
    Nieto, P.
    Garcia, C.
    Belda, S.
    Cabeza, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 378 - 378
  • [12] Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
    Garnock-Jones, Karly P.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2015, 16 (04) : 323 - 330
  • [13] Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
    Karly P. Garnock-Jones
    American Journal of Clinical Dermatology, 2015, 16 : 323 - 330
  • [14] Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
    Blauvelt, Andrew
    Armstrong, April W.
    Langley, Richard G.
    Gebauer, Kurt
    Thaci, Diamant
    Bagel, Jerry
    Guenther, Lyn C.
    Paul, Carle
    Randazzo, Bruce
    Flavin, Susan
    Hsu, Ming-Chun
    You, Yin
    Reich, Kristian
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2317 - 2324
  • [15] Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study
    Gottlieb, Alice B.
    Merola, Joseph F.
    Reich, Kristian
    Behrens, Frank
    Nash, Peter
    Bao, Weibin
    Pellet, Pascale
    Pricop, Luminita
    McInnes, Iain B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB92 - AB92
  • [16] Secukinumab efficacy and safety in Asian subjects with moderate to severe plaque psoriasis: Pooled analysis from the FIXTURE and ERASURE phase III clinical studies
    Lee, Jeung-Hoon
    Morita, Akimichi
    Tsai, Tsen-Fang
    Zheng, Eugene
    Ko, Luke
    Fox, Todd
    Langley, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB249 - AB249
  • [17] Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors
    Egeberg, A.
    Skov, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 222 - 223
  • [18] Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
    Pan Ran
    Wang Xiaolun
    Shu Min
    Das Jaydeep
    Kalra Manik
    Wang Zhidong
    中华医学杂志英文版, 2022, 135 (01) : 11 - 19
  • [19] Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling
    Liu, Yixiao
    Xu, Ling
    Wang, Xinrui
    Wu, Lijuan
    Cai, Ruifen
    Li, Lujin
    Zheng, Qingshan
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (10) : 999 - 1008
  • [20] Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
    Pan, Ran
    Wang, Xiaolun
    Shu, Min
    Das, Jaydeep
    Kalra, Manik
    Wang, Zhidong
    CHINESE MEDICAL JOURNAL, 2022, 135 (01) : 11 - 19
12345